Archynetys Live news trend intelligence
▲ Peaking Health

Aneuploidy selects for the acquisition of driver genes in breast cancer

New research reveals how aneuploidy enables the acquisition of driver genes in basal-like breast cancer, uncovering 81 previously unknown targets.

5sources
5articles
3velocity
+40%since first seen
20m agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

The brief

Recent findings indicate that aneuploidy drives the acquisition of key genes involved in the progression of breast cancer. A study conducted by Sinai Health utilizing mouse models identified 90 genes driving basal-like breast cancer.

Coverage from Nature, EurekAlert!, Bioengineer.org, and Medical Xpress emphasizes that 81 of the identified genes had not been previously linked to the disease. These findings are described as addressing a long-standing mystery regarding the deadliest form of breast cancer.

Future developments center on the potential for these 81 newly identified genes to serve as treatment targets.

Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 18m ago.

Quick answers

What role does aneuploidy play in breast cancer?

According to coverage, aneuploidy selects for the acquisition of driver genes that contribute to cancer progression.

How many new genes were identified in the Sinai Health study?

The study identified 90 genes, 81 of which had not been previously linked to basal-like breast cancer.

What was the methodology used for the Sinai Health research?

The research was conducted as a mouse study.

Coverage (5)

Topics

Related trends